Cargando…
An Advanced in Silico Modelling of the Interaction between FSCPX, an Irreversible A(1) Adenosine Receptor Antagonist, and NBTI, a Nucleoside Transport Inhibitor, in the Guinea Pig Atrium
In earlier studies, we generated concentration-response (E/c) curves with CPA (N(6)-cyclopentyladenosine; a selective A(1) adenosine receptor agonist) or adenosine, in the presence or absence of S-(2-hydroxy-5-nitrobenzyl)-6-thioinosine (NBTI, a selective nucleoside transport inhibitor), and with or...
Autores principales: | Szabo, Adrienn Monika, Erdei, Tamas, Viczjan, Gabor, Kiss, Rita, Zsuga, Judit, Papp, Csaba, Pinter, Akos, Juhasz, Bela, Szilvassy, Zoltan, Gesztelyi, Rudolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630508/ https://www.ncbi.nlm.nih.gov/pubmed/31212849 http://dx.doi.org/10.3390/molecules24122207 |
Ejemplares similares
-
FSCPX, a Chemical Widely Used as an Irreversible A(1) Adenosine Receptor Antagonist, Modifies the Effect of NBTI, a Nucleoside Transport Inhibitor, by Reducing the Interstitial Adenosine Level in the Guinea Pig Atrium
por: Erdei, Tamas, et al.
Publicado: (2018) -
A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A(1) Adenosine Receptor Antagonist So Far
por: Viczjan, Gabor, et al.
Publicado: (2021) -
Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A(1) Adenosine Receptor Agonists
por: Szabo, Adrienn Monika, et al.
Publicado: (2019) -
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life
por: Zsuga, Judit, et al.
Publicado: (2017) -
The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the zucker diabetic fatty (ZDF) rat atrium
por: Viczjan, Gabor, et al.
Publicado: (2022)